Clinical trial
Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
NCT03219476
Study timeline
Study start (actual)2017-02-05Date precision: day
Registry last updated2025-04-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Invasive Breast Cancerunresolved
Interventions
AnastrozoleDRUG · verified · RxNorm: anastrozole
LetrozoleDRUG · verified · RxNorm: letrozole
ExemestaneDRUG · verified · RxNorm: exemestane
TamoxifenDRUG · verified · RxNorm: tamoxifen
Sponsors & collaborators
Medical College of Wisconsinlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03219476 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.